Kiniksa Pharmaceuticals, Ltd. logo

Kiniksa Pharmaceuticals, Ltd.

NASDAQ:KNSA

Overview | Financials
Company Name Kiniksa Pharmaceuticals, Ltd.
Symbol KNSA
Currency USD
Price 20.02
Market Cap 1,445,475,291
Dividend Yield 0%
52-week-range 16.56 - 28.15
Industry Biotechnology
Sector Healthcare
CEO Mr. Sanj K. Patel
Website https://www.kiniksa.com

An error occurred while fetching data.

About Kiniksa Pharmaceuticals, Ltd.

Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatment of recurrent pericarditis, which is an inflammatory cardiovascular disease; Mavrilimumab, a

Related Stocks

Gossamer Bio, Inc. logo

Gossamer Bio, Inc.

GOSS

1.09 USD

Pharvaris N.V. logo

Pharvaris N.V.

PHVS

18.06 USD

Rani Therapeutics Holdings, Inc. logo

Rani Therapeutics Holdings, Inc.

RANI

1.49 USD

Inogen, Inc. logo

Inogen, Inc.

INGN

9.51 USD

Relmada Therapeutics, Inc. logo

Relmada Therapeutics, Inc.

RLMD

0.44 USD

PMV Pharmaceuticals, Inc. logo

PMV Pharmaceuticals, Inc.

PMVP

1.57 USD

Aveanna Healthcare Holdings Inc. logo

Aveanna Healthcare Holdings Inc.

AVAH

4.51 USD

Financials

Numbers are in millions USD

Numbers are in millions USD